UniSa - IRIS Institutional Research Information System

SABBATINO, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.693
EU - Europa 575
AS - Asia 377
OC - Oceania 5
AF - Africa 2
Totale 2.652
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.685
IT - Italia 249
CN - Cina 155
IE - Irlanda 97
VN - Vietnam 91
TR - Turchia 88
SE - Svezia 65
UA - Ucraina 59
IN - India 29
DE - Germania 20
AT - Austria 16
FR - Francia 16
GB - Regno Unito 14
FI - Finlandia 10
CZ - Repubblica Ceca 8
CA - Canada 7
NP - Nepal 7
PL - Polonia 7
RU - Federazione Russa 7
NZ - Nuova Zelanda 4
TH - Thailandia 4
HK - Hong Kong 2
NL - Olanda 2
AU - Australia 1
EG - Egitto 1
ES - Italia 1
LT - Lituania 1
PA - Panama 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 2.652
Salva come PNG Salva come JPEG
Città #
Ann Arbor 379
Chandler 300
Princeton 275
Dublin 93
Dong Ket 91
Izmir 87
Jacksonville 83
Wilmington 70
Ashburn 69
Naples 67
Beijing 58
Andover 56
Pellezzano 52
Houston 32
Nanjing 31
Salerno 30
Boardman 25
Woodbridge 25
Fairfield 19
Pune 17
Nanchang 16
Vienna 16
Changsha 13
Norwalk 13
Paris 10
Los Angeles 9
San Diego 9
Brno 8
Jiaxing 8
Kathmandu 7
Orange 7
Seattle 7
Shenyang 7
Warsaw 7
Fisciano 6
Hebei 6
Washington 6
Cambridge 5
Lappeenranta 5
New York 5
Redwood City 5
Toronto 5
Zhengzhou 5
Cellole 4
Chiang Mai 4
Dearborn 4
Mercato San Severino 4
Milan 4
San Gennaro Vesuviano 4
Stella Cilento 4
Tianjin 4
Auckland 3
Carbonara di Nola 3
Delhi 3
Jinan 3
Munich 3
Aiello Del Sabato 2
Baltimore 2
Chandigarh 2
Desio 2
Draper 2
Düsseldorf 2
Edinburgh 2
Fremont 2
Guwahati 2
Hong Kong 2
Mele 2
Moscow 2
Mumbai 2
Novara 2
Nürnberg 2
Reggio Calabria 2
San Cipriano Picentino 2
San Giorgio A Cremano 2
San Martino Valle Caudina 2
Scuola 2
St Petersburg 2
Amsterdam 1
Arba 1
Bagno A Ripoli 1
Belgrade 1
Burnaby 1
Bury 1
Cairo 1
Calgary 1
Cardito 1
Christchurch 1
Craigavon 1
Falkenstein 1
Groningen 1
Haikou 1
Istanbul 1
Jonesboro 1
Kochi 1
Kozhikode 1
Krasnodar 1
London 1
Luzzano 1
Madrid 1
Marigliano 1
Totale 2.156
Salva come PNG Salva come JPEG
Nome #
Cell growth-inhibition and cell cycle perturbations induced by a new synthetic iminoquinone, 5H-pyridophenoxazin-5-one, in human breast carcinoma cell lines. 94
The farnesyltransferase inhibitor R115777 (Zanestra) synergizes with ionizing radiation in inducing cell cycle perturbation and growth inhibition of human epidermoid head and neck cancer cells. 85
Inhibition of NF-kB activity potentiates ionizing radiation and cisplatin induced cell killing of anaplastic thyroid carcinoma cells AACR Meeting Abstracts, Apr 2006; 2006: 1038. 84
Counteracting resistance to treatments in solid tumors. 78
Abstract 4017: Anti-tumor activity of a BRAF inhibitor and IFNα combination in BRAF mutant melanoma 70
Effect of p53 activity on the sensitivity of human glioblastoma cells to PARP-1 inhibitor in combination with topoisomerase i inhibitor or radiation 61
Antitumor activity of BRAF inhibitor and IFN×alpha; Combination in BRAF-mutant melanoma 60
Abstracts of CIRSE (Cardiovascular and Interventional Radiological Society of Europe) 2011. September 10-14, 2011. Munich, Germany 60
Abstracts of CIRSE (Cardiovascular and Interventional Radiological Society of Europe) 2010. October 2-6, 2010. Valencia, Spain 59
Abstract 3703: PDGFRα up-regulation mediated by Sonic Hedgehog Pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation 59
Abstract 3639: Combinatorial therapy for triple negative breast cancer 55
Abstract 3132: Single nucleotide polymorphisms (SNPs) in PD-L1 as predictive biomarkers for checkpoint inhibitor based-immunotherapy in caucasian patients with advanced NSCLC 54
Enhanced Expression of CD47 Is Associated With Off-Target Resistance to Tyrosine Kinase Inhibitor Gefitinib in NSCLC 53
Anti-proliferative and pro-apoptotic activity of GD2 ganglioside-specific monoclonal antibody 3F8 in human melanoma cells 50
Abstract 4741: Inhibition of TNBC cell growth by CSPG4-specific mAb 225.28 with a Sonic Hedgehog pathway inhibitor 49
Blocking the formation of radiation-induced breast cancer stem cells 49
The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology 47
Immunohistochemical algorithms and gene expression profiling in primary cutaneous B-cell lymphoma 47
Variability in immune infiltrates and HLA expression in cholangiocarcinoma 46
Real-world experience with the Sydney System on 1458 cases of lymph node fine needle aspiration cytology 45
597 IMPACT OF CONTRAST-ENHANCED ULTRASONOGRAPHY ON DIAGNOSTIC WORK-UP OF FOCAL LIVER ANOMALIES: EXPERIENCE IN A SINGLE HEPATOLOGY UNIT 44
Peritumoral Immune Infiltrate as a Prognostic Biomarker in Thin Melanoma 44
Interfering with the Tumor-Immune Interface: Making Way for Triazine-Based Small Molecules as Novel PD-L1 Inhibitors 43
Multidisciplinary approach to patient with malignant melanoma 39
P.1.279: ADVANCED HCC ABLATION AFTER DOWSTAGING WITH SORAFENIB 39
Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015 39
Epigenetic control of gene expression: Potential implications for cancer treatment 39
Role of Human Leukocyte Antigen System as A Predictive Biomarker for Checkpoint-Based Immunotherapy in Cancer Patients 39
A genotyping/phenotyping approach with careful clinical monitoring to manage the fluoropyrimidines-based therapy: Clinical cases and systematic review of the literature 39
COX-2 expression positively correlates with PD-L1 expression in human melanoma cells 38
Detection of chondroitin sulfate proteoglycan 4 (CSPG4) in melanoma 38
A specific miRNA signature correlates with complete pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer 38
PHH3 immunostaining: a novel prognostic biomarker in pancreatic neuroendocrine tumors 36
"Idealized" vs. "true" learning curves: The case of laparoscopic liver resection 36
Ipilimumab in the treatment of metastatic melanoma: Management of adverse events 35
Can the "right" EGFR-specific mAb dramatically improve EGFR-targeted therapy? 34
Ki67 in Gleason Pattern 3 as a Marker of the Presence of Higher-Grade Prostate Cancer 34
Molecules and mechanisms to overcome oxidative stress inducing cardiovascular disease in cancer patients 34
P.1.159: REPEATED LOCO-REGIONAL TREATMENTS: HIGH SURVIVAL RATES IN CIRRHOTIC PATIENTS WITH HEPATOCELLULAR CARCINOMA HIGHLY COMPLIANT TO SCHEDULED FOLLOW-UP 33
Grp94-specific monoclonal antibody to counteract BRAF inhibitor resistance in BRAFV600E melanoma 33
Immune Checkpoint Inhibitors in Melanoma and HIV Infection 31
Translational Research in Cutaneous Melanoma: New Therapeutic Perspectives 30
Emerging BRAF inhibitors for melanoma 29
Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer 28
Harnessing host innate immunity may combat acquired resistance to BRAFi 27
XXV Conferenza Nazionale di Citometria: CELL GROWTH INHIBITION AND CELL CYCLE PERTURBATIONS INDUCED BY A NEW SYNTHETIC IMINOQUINONE, 5H-PYRIDOPHENOXAZIN-5-ONE, IN HUMAN BREAST CARCINOMA CELL LINES 27
XXV Conferenza Nazionale di Citometria: INHIBITION OF POLY (ADP-RIBOSE) POLYMERASE SYNERGIZES WITH THE DNA-TOPOISOMERASE-1-INHIBITOR, TOPOTECAN, AND RADIATION IN HUMAN GLIOBLASTOMA CELL LINE 26
Phosphorylated Histone H3 (PHH3) Is a Superior Proliferation Marker for Prognosis of Pancreatic Neuroendocrine Tumors 26
Genetic evolution of T-cell resistance in the course of melanoma progression 25
Resistance to anti-PD-1-based immunotherapy in basal cell carcinoma: a case report and review of the literature 25
PD-L1 Dysregulation in COVID-19 Patients 25
Identification of Drug Interaction Adverse Events in Patients with COVID-19: A Systematic Review 25
The ratio of grzb+ − foxp3+ over cd3+ t cells as a potential predictor of response to nivolumab in patients with metastatic melanoma 23
Effect of tocilizumab in reducing the mortality rate in covid-19 patients: A systematic review with meta-analysis 23
Proceedings of the XXII National Conference of the Italian Society of Cytometry GIC, October 4–8, 2005, San Bendetto del Tronto (AP), Italy 22
P.1.112: IMPACT OF CONTRAST-ENHANCED ULTRASONOGRAPHY ON DIAGNOSTIC WORK-UP OF FOCAL LIVER ANOMALIES: EXPERIENCE IN A SINGLE HEPATOLOGY UNIT 22
A novel chemoradiation targeting stem and nonstem pancreatic cancer cells by repurposing disulfiram 21
Case Report: BAP1 Mutation and RAD21 Amplification as Predictive Biomarkers to PARP Inhibitor in Metastatic Intrahepatic Cholangiocarcinoma 21
Clinical and Molecular Characteristics of Rare Malignant Tumors of Colon and Rectum 21
Long COVID: Clinical Framing, Biomarkers, and Therapeutic Approaches 20
Evolution of studies of HLA class I antigen processing machinery (APM) components in malignant cells 20
Testing egfr with idylla on cytological specimens of lung cancer: A review 20
Chondroitin sulfate proteoglycan 4 expression in chondrosarcoma: A potential target for antibody-based immunotherapy 19
PD-L1 and HLA class i antigen expression and clinical course of the disease in intrahepatic cholangiocarcinoma 19
PDGFRa up-regulation mediated by sonic hedgehog pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation 19
Immune checkpoint inhibitors for the treatment of melanoma 19
Cancer Cell Metabolism Reprogramming and Its Potential Implications on Therapy in Squamous Cell Carcinoma of the Head and Neck: A Review 18
HLA class I downregulation is associated with enhanced NK-cell killing of melanoma cells with acquired drug resistance to BRAF inhibitors 18
Novel tumor antigen-specific monoclonal antibody-based immunotherapy to eradicate both differentiated cancer cells and cancer-initiating cells in solid tumors 18
Tumor Antigen-Specific Monoclonal Antibody-Based Immunotherapy, Cancer Initiating Cells and Disease Recurrence 18
Melanoma initiating cells: where do we stand? 17
Novel combinatorial therapy for pancreatic adenocarcinoma 17
A monocentric phase I study of vemurafenib plus cobimetinib plus PEG-interferon (VEMUPLINT) in advanced melanoma patients harboring the V600BRAF mutation 17
Tissue micro arrays for immunohistochemical detection of inflammatory infiltrates in renal cell carcinoma 16
Monoclonal antibody-based immunotherapy of ovarian cancer: Targeting ovarian cancer cells with the B7-H3-specific mAb 376.96 15
Tumor Microenvironment Immune Response in Pancreatic Ductal Adenocarcinoma Patients Treated with Neoadjuvant Therapy 15
Defective HLA Class I Expression and Patterns of Lymphocyte Infiltration in Chordoma Tumors 15
Concomitant Administration of Capecitabine and Folate Supplements: Need to Encourage Medication Reconciliation 12
High TIL, HLA, and Immune Checkpoint Expression in Conventional High-Grade and Dedifferentiated Chondrosarcoma and Poor Clinical Course of the Disease 10
Bispecific Antibodies: A Novel Approach for the Treatment of Solid Tumors 9
Impact of Epstein Barr Virus Infection on Treatment Opportunities in Patients with Nasopharyngeal Cancer 8
rs822336 binding to C/EBPβ and NFIC modulates induction of PD-L1 expression and predicts anti-PD-1/PD-L1 therapy in advanced NSCLC 7
Survival and Toxicities of Metastatic Colorectal Cancer Patients Treated with Regorafenib before TAS-102 or Vice Versa: A Mono-Institutional Real-Practice Study 7
BRAF p.V600E mutation as a molecular boundary between genuine oligo-repeated and poly-metastatic disease in colorectal cancer 6
An economic evaluation of fine-needle cytology as the primary diagnostic tool in the diagnosis of lymphadenopathy 6
KRAS p.G12C Mutation in Metastatic Colorectal Cancer: Prognostic Implications and Advancements in Targeted Therapies 5
Interplay between B7–H3 and HLA class I in the clinical course of pancreatic ductal adenocarcinoma 5
Exploring the Spectrum of VEGF Inhibitors’ Toxicities from Systemic to Intra-Vitreal Usage in Medical Practice 5
Oligo-Metastatic Cancers: Putative Biomarkers, Emerging Challenges and New Perspectives 5
Hypertension, type 2 diabetes, obesity, and p53 mutations negatively correlate with metastatic colorectal cancer patients' survival 5
From Chaos to Opportunity: Decoding Cancer Heterogeneity for Enhanced Treatment Strategies 4
The prognostic role of p53 mutations in metastatic colorectal cancer: A systematic review and meta-analysis 4
Different Prognostic Role of Soluble PD-L1 in the Course of Severe and Non-Severe COVID-19 3
Emerging treatment approaches for triple-negative breast cancer 3
21st ISoP Annual Meeting “A New Era of Pharmacovigilance: Challenges and Opportunities” 20–23 September 2022 Verona, Italy 2
Bibliometric and Visual Analysis of the Scientific Literature on Percutaneous Electrical Nerve Stimulation (PENS) for Pain Treatment 2
Translational Insights in the Landscape of Salivary Gland Cancers: Ready for a New Era? 2
Writing the paper “Unveiling artificial intelligence: an insight into ethics and applications in anesthesia” implementing the large language model ChatGPT: a qualitative study 2
Cytopathological differential diagnosis of malignant tumor cells in the cerebrospinal fluid: A retrospective analysis 1
Back to the Bench: Unveiling the Tissue Context is Crucial to Enhance the Efficacy of Agnostic Therapies in Oncology 1
Totale 2.870
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.452
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.452
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019100 0 0 0 0 0 0 0 0 0 11 87 2
2019/2020287 117 0 20 0 4 3 12 7 9 19 87 9
2020/2021220 10 6 12 7 9 19 20 3 6 1 19 108
2021/2022462 7 0 2 1 22 4 2 19 79 50 66 210
2022/2023745 77 80 68 126 54 143 1 48 96 1 41 10
2023/2024393 41 41 37 37 37 59 44 29 35 33 0 0
Totale 2.878